Pharmabiz

Novo Nordisk announces China’s Supreme People’s Court delivers positive ruling on semaglutide compound patent

Novo Nordisk announces China’s Supreme People’s Court delivers positive ruling on semaglutide compound patent: Bagsværd, Denmark Saturday, January 3, 2026, 17:00 Hrs [IST] Th ...
Pharmabiz

BioAtla and GATC Health announce $40 million SPV transaction to advance ozuriftamab vedotin into a registrational trial for 2L+ OPSCC

BioAtla and GATC Health announce $40 million SPV transaction to advance ozuriftamab vedotin into a registrational trial for 2L+ OPSCC: San Diego Saturday, January 3, 2026, 18:00 H ...
Pharmabiz

FibroBiologics submits IND application with US FDA to initiate clinical trials of CYPS317 in psoriasis patients

FibroBiologics submits IND application with US FDA to initiate clinical trials of CYPS317 in psoriasis patients: Houston Saturday, January 3, 2026, 11:00 Hrs [IST] FibroBiologics ...
Pharmabiz

Pharma industry leaders spotlight quality, sustainability and market diversification as export priorities for 2026

Pharma industry leaders spotlight quality, sustainability and market diversification as export priorities for 2026: Our ...
Pharmabiz

Corcept receives US FDA Complete Response Letter for relacorilant as a treatment for patients with hypercortisolism

Corcept receives US FDA Complete Response Letter for relacorilant as a treatment for patients with hypercortisolism: Redwood City, California Saturday, January 3, 2026, 14:00 Hrs ...
Pharmabiz

Advances in technology transforming the approach to prostate cancer: Dr Likhiteswer Pallagani

Advances in technology transforming the approach to prostate cancer: Dr Likhiteswer Pallagani: Shardul Nautiyal, Mumbai ...
Pharmabiz

USDA approves Elanco Animal Health’s Befrena, a new anti-IL31 mAb injection targeting canine allergic and atopic dermatitis

Indianapolis, Indiana Saturday, January 3, 2026, 10:00 Hrs [IST] ...
Pharmabiz

Xortx Therapeutics announces pioneering research on genome-wide pathogenic pathways in gout

Xortx Therapeutics announces pioneering research on genome-wide pathogenic pathways in gout: Calgary, Alberta Saturday, January 3, 2026, 13:00 Hrs [IST] Xortx Therapeutics Inc., a ...
Pharmabiz

US FDA accepts Axsome Therapeutics’ supplemental New Drug Application for AXS-05 to treat Alzheimer’s disease agitation

US FDA accepts Axsome Therapeutics’ supplemental New Drug Application for AXS-05 to treat Alzheimer’s disease agitation: New York Saturday, January 3, 2026, 12:00 Hrs [IST] Ax ...
Pharmabiz

Intelligent Bio Solutions partners with Syrma Johari to strengthen global production capability

Intelligent Bio Solutions partners with Syrma Johari to strengthen global production capability: New York Saturday, January 3, 2026, 09:00 Hrs [IST] Intelligent Bio Solutions Inc, ...
Pharmabiz

Delcath Systems announces publication of subgroup analyses of phase 3 FOCUS study of Melphalan/Hepatic Delivery System in patients with unresectable metastatic uveal melanoma

Delcath Systems announces publication of subgroup analyses of phase 3 FOCUS study of Melphalan/Hepatic Delivery System in patients with unresectable metastatic uveal melanoma Queensbury, New York ...
Pharmabiz

Haryana & Telangana begin crackdown on nimesulide above 100 mg in immediate-release dosage forms

Haryana & Telangana begin crackdown on nimesulide above 100 mg in immediate-release dosage forms: Peethaambaran Kunnathoor, Chennai Saturday, January 3, 2026, 08:00 Hrs [IST] Foll ...